Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
465 GBX | -0.85% | +9.67% | +27.40% |
04-24 | EDX Medical to begin trading on Apex segment of AQSE next week | AN |
04-23 | Marula reaches "significant milestone" for Tanzanian graphite projects | AN |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company benefits from high valuations in earnings multiples.
- With an enterprise value anticipated at 4.72 times the sales for the current fiscal year, the company turns out to be overvalued.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
Ratings chart - Surperformance
Sector: Financial & Commodity Market Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+27.40% | 153M | - | ||
+0.16% | 75.94B | B | ||
+12.06% | 21.7B | C+ | ||
+27.19% | 12.54B | C+ | ||
+41.22% | 8.36B | C+ | ||
-0.13% | 7.96B | B- | ||
-2.16% | 2.96B | C+ | ||
+30.25% | 2.55B | C | ||
-5.45% | 1.69B | C | ||
+13.86% | 1.29B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- AQX Stock
- Ratings Aquis Exchange PLC